SPY—QQQ—BTC/USD—DIA—GLD—TLT—
Benzinga
Updated: Oct 19, 2026

Jared Haase's Stock Ratings

William Blair Analyst

Jared Haase is an analyst at William Blair. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends.

Overall Average Return

42.2%

Smart Score

77.4%

Overall Average Return Percentile

91st

Number of Ratings

5
Buy NowGet Alert
07/01/2026CONBuy Now
Concentra Group Holdings
$38.40——Initiates → OutperformGet Alert
12/08/2025BTSGBuy Now
BrightSpring Health
$61.29——Initiates → OutperformGet Alert
12/08/2025PNTGBuy Now
Pennant Gr
$40.66——Initiates → OutperformGet Alert
12/08/2025AVAHBuy Now
Aveanna Healthcare Hldgs
$12.28——Initiates → OutperformGet Alert
02/05/2024ADUSBuy Now
Addus HomeCare
$115.16——Assumes → OutperformGet Alert

Recent Analyst Stock Rating News

OPKO Health Sheds Diagnostics Businesses in Major Labcorp Deal
OPKO Health Sheds Diagnostics Businesses in Major Labcorp Deal
OPKO Health jumps 18% and Labcorp trades higher as LH acquires BioReference Health assets in an $872M deal.
Lifecore Biomedical Q2 2026 Earnings Call Transcript
Lifecore Biomedical Q2 2026 Earnings Call Transcript
Lifecore Biomedical (NASDAQ:LFCR) held its second-quarter earnings conference call on Wednesday. Below is the complete transcript from the call. This content is powered by Benzinga APIs. For comprehensive financial data
Fortrea Leverages Early Phase Strengths to Accelerate Market Expansion
Fortrea Leverages Early Phase Strengths to Accelerate Market Expansion
Fortrea acquires Worldwide Clinical Trials' Early Phase division for $45 million in cash to expand its clinical research network.
Aveanna Raises Outlook After Family First Buy
Aveanna Raises Outlook After Family First Buy
Aveanna Healthcare ($AVAH) boosts 2026 guidance, projecting up to $2.65B in revenue and $342M in adjusted EBITDA after Family First buyout.
BrightSpring Extends Rally With Solid Q1, Upgraded Fiscal 2026 Forecast
BrightSpring Extends Rally With Solid Q1, Upgraded Fiscal 2026 Forecast
BrightSpring shares rise after Q1 earnings beat, revenue growth and raised FY26 guidance; analysts cite momentum but note valuation premium.
Encompass Health Q1 2026 Earnings Call: Complete Transcript
Encompass Health Q1 2026 Earnings Call: Complete Transcript
Creative Agencies Offer Free Services To Struggling Cannabis Companies
Creative Agencies Offer Free Services To Struggling Cannabis Companies
Cannabis-focused branding and marketing agency, Jared Mirksy-led Wick & Mortar, has been the driving creative force behind some of the industries largest brands.
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved